Search

Ya sea que le hayan diagnosticado un tipo de cáncer poco común u otro más común, los médicos de MSK pueden brindarle una segunda opinión.

… Thursday, December 18, 2025 Enterarse de que tiene cáncer puede ser una experiencia abrumadora. Al comenzar a investigar cómo proceder luego de recibir un  diagnóstico de cáncer , probablemente escuche hablar mucho de una segunda opinión. Memorial Sloan Kettering Cancer Center (MSK) da segundas opiniones

Paige Arnold, who will graduate from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) next spring, has been awarded the 2022 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Emeritus Louis V. Gerstner, Jr., for whom the school is named.

… Friday, September 9, 2022 Paige Arnold , who will graduate from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) next spring, has been awarded the 2022 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Emeritus

A new drug delivery method could improve treatment of a lethal pediatric brain tumor called diffuse intrinsic pontine glioma.

… Friday, March 14, 2025 Brain tumors are one of the most difficult cancers to treat because of the blood-brain barrier, which protects the brain against toxins. That barrier also means treatments such as chemotherapy  can’t be delivered to tumors in high enough concentrations to be effective. As a result

The final survival analysis of an international study of a new drug for prostate cancer has found an even greater median survival benefit than previously reported, and has established a new class of treatment for men with metastatic prostate cancer. In addition, researchers are exploring a potential biomarker of response to treatment in general.

… Saturday, June 4, 2011 The final survival analysis of an international study of a new drug for prostate cancer has found an even greater median survival benefit than previously reported, and has established a new class of treatment for men with metastatic prostate cancer. In addition, researchers are

Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA (mRNA) can inactivate the functions of tumor suppressor genes and thereby promote cancer. The findings pinpoint previously unknown drivers of the disease, indicating that cancer diagnostics need to go beyond the analysis of DNA mutations.

… Monday, August 27, 2018 Bottom Line: Researchers at the Sloan Kettering Institute have found that changes in an information-carrying molecule called messenger RNA (mRNA) can inactivate the functions of tumor suppressor genes and thereby promote cancer. The findings pinpoint previously unknown drivers

Receiving five or more cycles of neoadjuvant chemotherapy was associated with worse progression-free survival (PFS) and overall survival (OS) compared to receiving three or four cycles — despite maximal surgical cytoreduction.

… Friday, November 13, 2020 Receiving five or more cycles of neoadjuvant chemotherapy was associated with worse progression-free survival (PFS) and overall survival (OS) compared to receiving three or four cycles — despite maximal cytoreduction — according to a retrospective analysis of patients with newly-diagnosed

On June 7 when Memorial Sloan Kettering opened a facility housing the novel Center for Image-Guided Interventions, a suite of endoscopy rooms, and new operating rooms for the Surgical Day Hospital.

… Thursday, July 1, 2010 Summary On June 7 when Memorial Sloan Kettering opened a facility housing the novel Center for Image-Guided Interventions, a suite of endoscopy rooms, and new operating rooms for the Surgical Day Hospital. A vision of creating a state-of-the-art treatment center in which multiple

This photo essay showcases the critical role trainees play within MSK's research enterprise.

… Tuesday, September 3, 2024 The students and postdoctoral researchers who work and train in MSK’s laboratories drive discovery forward every day. Today they are vital partners. Tomorrow they will lead further progress at hospitals, research centers, and biomedical companies around the world.   Monica

People with bladder cancer may soon have a new treatment option following surgery.

… Thursday, May 13, 2021 Update: On August 19, 2021, the US Food and Drug Administration approved nivolumab for patients with bladder cancer who are at high risk of recurrence following surgery to remove the bladder.  People whose bladder cancer has spread into the muscle wall may soon have a new treatment

Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR.

… Wednesday, June 6, 2012 Summary Dr. Clarkson of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program was recognized for his more than three decades of work on behalf of the AACR. Bayard D. Clarkson, of the Sloan Kettering Institute’s Molecular Pharmacology and Chemistry Program